PDF icon PDF herunterladen
Open Access
CC BY 4.0 · Indian J Med Paediatr Oncol
DOI: 10.1055/s-0045-1812017
Original Article

Symptom Clustering and Its Association with Treatment and Comorbidities in Advanced Head and Neck Cancer Patients: A Data-Driven Analysis

Chaitanya R. Patil
1   Department of Palliative Care, Kolhapur Cancer Center, Kolhapur, Maharashtra, India
,
Nilesh A. Dhamne 
2   Department of Medical Oncology, Kolhapur Cancer Center, Kolhapur, Maharashtra, India
,
Yogesh S. Anap
3   Department of Radiation Oncology, Kolhapur Cancer Center, Kolhapur, Maharashtra, India
,
Parag J. Watve
4   Department of Head & Neck Surgery, Kolhapur Cancer Center, Kolhapur, Maharashtra, India
,
Prasad T. Tanawade
3   Department of Radiation Oncology, Kolhapur Cancer Center, Kolhapur, Maharashtra, India
› Institutsangaben
Funding None.
› Weitere Informationen
Auch verfügbar aufeRef
  Lizenzen und Reprints
Preview

Abstract

Introduction

Head and neck cancers (HNCs) are frequently associated with a complex symptom burden caused by both the disease and its treatment modalities, including surgery, radiotherapy, and chemotherapy. These symptoms often appear in clusters rather than as isolated events, considerably impairing patients' quality of life. Identifying these symptom clusters and understanding their relationships with treatment types and comorbidities is crucial for improving targeted symptom management.

Objective

The aim of this study was to identify symptom clusters in patients with advanced HNC and evaluate their associations with treatment modalities and coexisting health conditions.

Materials and Methods

A prospective observational study was conducted at the Department of Palliative Care, Kolhapur Cancer Center, from August 2021 to August 2024. A total of 400 patients with HNC undergoing chemotherapy, radiotherapy, or both were included. Symptom data were collected using the Edmonston Symptom Scale, evaluating pain, fatigue, nausea, depression, anxiety, anorexia, weight loss, dysphagia, and voice changes. Patient demographics, treatment details, and comorbidities (diabetes, hypertension, and ischemic heart disease) were recorded. Statistical analyses included exploratory factor analysis, K-means, and hierarchical clustering to identify symptom patterns. Associations were analyzed using ANOVA and chi-square tests.

Results

Five distinct symptom clusters were identified: (1) high symptom burden, (2) pain and swallowing difficulties, (3) nausea and anxiety dominant, (4) fatigue with swallowing issues, and (5) weight loss with severe dysphagia. Radiotherapy was significantly associated with clusters involving dysphagia and weight loss (p < 0.0001). Diabetes (p = 0.0010) and hypertension (p < 0.0001) were also significantly related to increased symptom severity. Chemotherapy showed no significant association with symptom clustering. Hierarchical clustering and principal component analysis confirmed the consistency of these patterns.

Conclusion

The study emphasizes the clinical value of recognizing symptom clusters in patients with HNC. Significant associations with radiotherapy and comorbid conditions suggest the need for tailored symptom management strategies. Future research should focus on longitudinal tracking and the integration of machine learning techniques to further refine symptom classification and personalize care.

Keywords

head and neck cancer - symptom clusters - radiotherapy - chemotherapy - palliative care - comorbidities - symptom management

Patient Consent

Informed consent has been taken from all the patients.




Publikationsverlauf

Artikel online veröffentlicht:
23. September 2025

© 2025. The Author(s). This is an open access article published by Thieme under the terms of the Creative Commons Attribution License, permitting unrestricted use, distribution, and reproduction so long as the original work is properly cited. (https://creativecommons.org/licenses/by/4.0/)

Thieme Medical and Scientific Publishers Pvt. Ltd.
A-12, 2nd Floor, Sector 2, Noida-201301 UP, India